fluorodeoxyglucose f18 has been researched along with Atypical Ductal Hyperplasia in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (8.70) | 18.2507 |
2000's | 11 (47.83) | 29.6817 |
2010's | 7 (30.43) | 24.3611 |
2020's | 3 (13.04) | 2.80 |
Authors | Studies |
---|---|
Albatineh, AN; Sarikaya, A; Sarikaya, I; Sezer, YA; Tastekin, E | 1 |
Inoue, T; Noritake, M; Utsunomiya, D; Yamada, A; Yamanaka, S | 1 |
Akashi-Tanaka, S; Hashimoto, R; Ide, Y; Kobayashi, Y; Kuwayama, T; Masuda, H; Nakamura, S; Takamaru, T; Takimoto, M; Taruno, K; Watanabe, C | 1 |
Fujii, T; Hirakata, T; Kurozumi, S; Kuwano, H; Nakazawa, Y; Obayashi, S; Tokuda, S; Yajima, R; Yanai, K | 1 |
Eo, JS; Kim, WY; Lee, JB; Lee, S; Woo, SU | 1 |
Kim, BS; Kim, Y; Yoon, HJ | 1 |
Chisin, R; Freedman, N; Klein, M; Orevi, M; Peretz, T; Tahover, E; Uziely, B | 1 |
Kim, SH; Oh, JK; Park, SY; Seo, YY; Sohn, HS; Yoo, IR | 1 |
Bitencourt, AG; Chojniak, R; Conrado, JL; Lima, EN; Macedo, BR; Marques, EF | 1 |
Kasami, M; Uematsu, T; Yuen, S | 1 |
El-Kholy, MR; El-Shorbagy, E; Murakami, K; Zytoon, AA | 1 |
Azuma, A; Fukuma, E; Ito, K; O'uchi, T; Tanaka, T; Tozaki, M | 1 |
Beorlegui, C; García-Velloso, MJ; Gil-Rendo, A; Martínez-Regueira, F; Rodriguez-Spiteri, N; Zornoza, G | 1 |
Inoue, H; Isaji, S; Takei, Y | 1 |
Choi, BB; Jeong, SH; Kang, BJ; Kim, SH; Lee, JH; Song, BJ; Yim, HW | 1 |
Fehr, MK; Goerres, GW; Kamel, EM; von Schulthess, GK; Wyss, MT | 1 |
Aikou, T; Kijima, Y; Natsugoe, S; Owaki, T; Uenosono, Y; Yoshinaka, H; Yoshioka, T | 1 |
Drumm, D; Korn, RL; Kovalsky, ER; Layton, TA; May, CC; Orth, KM; Yost, AM | 1 |
Barandela, J; González-Alenda, J; Maldonado, A; Ruibal, A; Sánchez Salmón, A | 1 |
Abe, Y; Asakawa, H; Fukatsu, K; Hama, Y; Ishida, J; Kondo, N; Mochizuki, H; Shigekawa, T; Tamura, K; Tsuda, H; Ueda, S; Yamamoto, M | 1 |
Dalbohm, NM; Glaspy, JA; Hawkins, RA; Hoh, CK; Moser, EA; Nitzsche, EU; Phelps, ME | 1 |
Broussard, WF; Hortobagyi, GN; Kim, EE; Nieweg, OE; Singletary, SE; Tilbury, RS; Wong, WH | 1 |
Brix, G; Doll, J; Haberkorn, U; Henze, M; Knopp, MV; Lucht, R; Trojan, H; Zaers, J | 1 |
1 trial(s) available for fluorodeoxyglucose f18 and Atypical Ductal Hyperplasia
Article | Year |
---|---|
Is (18)F-FDG PET/CT an accurate tool for identifying metastases of lobular breast cancer?
Topics: Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
22 other study(ies) available for fluorodeoxyglucose f18 and Atypical Ductal Hyperplasia
Article | Year |
---|---|
Assessing the correlation between FDG PET findings of IDC breast carcinoma and histopathology of coexisting ductal carcinoma in-situ.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2022 |
Intraductal Papilloma With Carcinoma of the Breast Described by Dedicated Breast 18F-FDG PET.
Topics: Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Fluorodeoxyglucose F18; Humans; Papilloma, Intraductal | 2022 |
Diagnostic performance of dedicated breast positron emission tomography.
Topics: Breast; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen | 2022 |
Clinicopathological Features of Ductal Carcinoma
Topics: Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
Lymphadenopathy by tuberculosis seemed like metastasis on FDG PET/CT in patients with breast carcinoma.
Topics: Adult; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Lymphadenopathy; Lymphatic Metastasis; Magnetic Resonance Imaging; Mastectomy, Segmental; Middle Aged; Paget's Disease, Mammary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tuberculosis; Tuberculosis, Lymph Node | 2019 |
Intratumoral metabolic heterogeneity predicts invasive components in breast ductal carcinoma in situ.
Topics: Adult; Aged; Biopsy; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Young Adult | 2015 |
Ductal carcinoma in situ and ductal carcinoma in situ with microinvasion: correlation of FDG uptake with histological and biological prognostic factors.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Receptor, ErbB-2; Retrospective Studies | 2017 |
Can positron emission mammography help to identify clinically significant breast cancer in women with suspicious calcifications on mammography?
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Breast Neoplasms; Calcinosis; Carcinoma, Intraductal, Noninfiltrating; Early Detection of Cancer; Female; Fibroadenoma; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2017 |
Comparison of FDG PET and MRI for evaluating the tumor extent of breast cancer and the impact of FDG PET on the systemic staging and prognosis of patients who are candidates for breast-conserving therapy.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2009 |
Dual time point FDG-PET/CT imaging... Potential tool for diagnosis of breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Ductal carcinoma in situ: correlation between FDG-PET/CT and histopathology.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Association between [18F]fluorodeoxyglucose uptake and prognostic parameters in breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Statistics, Nonparametric; Young Adult | 2009 |
Intraductal papillary neoplasm of bile duct detected on fluorodeoxyglucose-positron emission tomography performed for cancer scanning.
Topics: Carcinoma, Intraductal, Noninfiltrating; Common Bile Duct Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2009 |
Diffusion-weighted imaging and FDG PET/CT: predicting the prognoses with apparent diffusion coefficient values and maximum standardized uptake values in patients with invasive ductal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Immunoenzyme Techniques; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Grading; Positron-Emission Tomography; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Tomography, X-Ray Computed | 2012 |
[18F]-Fluorodeoxyglucose positron emission tomography in patients with suspected recurrence of breast cancer.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Mucin-1; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Ductal carcinoma in-situ of the breast detected by [F-18] fluorodeoxyglucose positron emission tomography.
Topics: Biopsy, Needle; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Japan; Mastectomy, Segmental; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Risk Assessment; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Treatment Outcome | 2006 |
Unexpected focal hypermetabolic activity in the breast: significance in patients undergoing 18F-FDG PET/CT.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Child; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Mammography; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2006 |
[18FDG-PET in patients with in situ breast carcinomas. A cause of false negative results].
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Analysis of Variance; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Tomography, X-Ray Computed | 2008 |
[Whole body positron emission tomography in breast cancer].
Topics: Adenocarcinoma; Adenofibroma; Adolescent; Adult; Aged; Breast Neoplasms; Carcinoma; Carcinoma, Intraductal, Noninfiltrating; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Prospective Studies; Tomography, Emission-Computed | 1993 |
Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer.
Topics: Adenocarcinoma; Adult; Breast; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed | 1993 |
[Diagnostic evaluation of the breast using PET: optimization of data acquisition and postprocessing].
Topics: Algorithms; Breast; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Radionuclide Imaging; Radiopharmaceuticals | 2000 |